Clinical trial
Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma
NCT00312000 · Dutch Colorectal Cancer Group, Other · Completed
Key facts
| NCT number | NCT00312000 |
|---|---|
| Title | Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma |
| Official title | A Randomised Study of Sequential Versus Combination Chemotherapy in Patients With Previously Untreated Advanced Colorectal Carcinoma |
| Lead sponsor | Dutch Colorectal Cancer Group, Other |
| Collaborators | Koningin Wilhelmina Fonds Sanofi Industry Hoffmann-La Roche |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Colorectal Cancer |
| Intervention type | Drug |
| Interventions | capecitabine-irinotecan, capecitabine+irinotecan (1st line) |
| Enrollment | 820 |
| Start date | Jan 1, 2003 |
| Primary completion | Feb 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Apr 7, 2006 |
| Last update posted | Sep 8, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: